MedPath

Developing a stepped approach to improving sexual function after treatment for gynaecological cancer

Not Applicable
Completed
Conditions
Cancer
Psycho-sexual difficulties following treatment for gynaecological cancer
Registration Number
ISRCTN12010952
Lead Sponsor
niversity College London (UK)
Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30798790 (added 27/02/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria

1. Women aged over 18 (with partners at their choice) treated for any gynaecological malignancy with surgery and/or chemotherapy and/or radiation at UCLH Gynaecological Cancer Centre or University Hospitals Bristol Gynaecological Cancer Centre
2. 3 months minimum post end of treatment
3. Any sexual orientation
4. With sexual function difficulties identified by initial screen (3 clinical questions within clinical interview posed by doctor or nurse)

Exclusion Criteria

1. Poor English
2. Current drug or alcohol abuse
3. Current sexual therapy or psychotherapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Primary endpoints – measures of feasibility:<br> 1. Rate of recruitment<br> 2. Consent rate to randomization and treatment<br> 3. Proportion of women stepping up from level 1 to 2, and level 2 to 3<br> 4. Proportion of women dropping out of therapy<br> 5. Number of usable data points from all measures at all time points<br> 6. Proportion of women lost to follow-up on trial measures<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath